Navigation Links
Intercept Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
Date:9/4/2012

NEW YORK, Sept. 4, 2012  /PRNewswire/ -- Intercept Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver diseases, announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its common stock.  All shares of the common stock to be sold in the offering will be offered by Intercept.  The number of shares to be offered and the price range for the offering have not yet been determined.

BofA Merrill Lynch is acting as sole book-running manager for the offering.  BMO Capital Markets is acting as lead manager and Needham & Company, LLC, Wedbush PacGrow Life Sciences and ThinkEquity LLC are acting as co-managers. 

A registration statement relating to these securities has been filed with the Securities and Exchange Commission, but has not yet become effective. These securities may not be sold and offers to buy may not be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, and there shall not be any sale of these securities in any state in which such an offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state.

The offering will be made only by means of a prospectus.  When available, copies of the preliminary prospectus relating to and describing the terms of the offering may be obtained from BofA Merrill Lynch, 222 Broadway, 7th Floor, New York, NY 10038, Attn: Prospectus Department, or via email, at dg.prospectus_requests@baml.com, or BMO Capital Markets, Attention: Equity Syndicate Department, 3 Times Square New York, NY 10036, Telephone: (80
'/>"/>

SOURCE Intercept Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Intercept Pharmaceuticals Closes $30 Million Series C Financing
2. Avanir Pharmaceuticals Announces Enrollment Of First Patient In Study Of AVP-923 For The Treatment Of Agitation In Patients With Alzheimers Disease
3. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
4. Elevation Pharmaceuticals Presents Positive Phase 2b Results for EP-101 in COPD Patients at the European Respiratory Society Annual Congress
5. Lexicon Pharmaceuticals To Present At The Stifel Nicolaus 2012 Healthcare Conference
6. Novation Supports New Development in the U.S. Biosimilar Pharmaceuticals Market
7. Arena Pharmaceuticals to Present at Upcoming Investor Conferences
8. Isis Pharmaceuticals Demonstrates The Potential Of Single-Stranded RNA-Like Antisense Technology To Activate The RNAi Pathway
9. Optimer Pharmaceuticals to Present at September 2012 Investor Conferences
10. Global RFID in Healthcare and Pharmaceuticals Industry
11. Isis Pharmaceuticals to Present at the 2012 Stifel Nicolaus Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015  Only a quarter of ... managing the patients they prescribe them to, according to ... School of Medicine (BUSM) and myCME , ... Daniel Alford, M.D. , director of BUSM,s ... program , said, "This indicates a critical need for ...
(Date:6/2/2015)... -- ErgoNurse, the leader in bedside safety management solutions, and Briggs ... the United States , have formalized a partnership to ... nursing markets. ... Thousands of healthcare professionals in acute ... the ErgoNurse products to stop unnecessarily utilizing their backs for ...
(Date:6/2/2015)... -- CytRx Corporation (NASDAQ: CYTR ), a biopharmaceutical research ... it has reached an agreement to settle the stockholder ... Court of Chancery, which names as defendants a ... officers, and names the Company as a nominal defendant. ... Corp. Stockholder Derivative Litigation , C.A. No. 9864-VCL, relates ...
Breaking Medicine Technology:Survey Results Show Few Doctors Are Very Confident Managing Patients on Opioids 2ErgoNurse and Briggs Healthcare Positioned to Completely Eliminate the Unnecessary Cost of Healthcare-Related Back Injuries 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4
... Vaginal Supplement Studied in Largest-Ever IVF Trial,in ... /PRNewswire/ -- Results of,four studies evaluating Ferring ... development for luteal phase,support (supplementation to provide ... pregnancy) in assisted reproductive,technologies (ART) were presented ...
... April 18, 2007,/PRNewswire-FirstCall/ -- Pharmacyclics, Inc. today ... a functional,biomarker for its novel histone deacetylase ... with its,Bruton's tyrosine kinase (BTK) inhibitor compounds. ... for Cancer Research (AACR),2007 Annual Meeting being ...
Cached Medicine Technology:Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 2Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 3Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 4Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 5Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 2Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 3Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 4Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 5
(Date:6/2/2015)... Detroit, MI (PRWEB) June 02, 2015 ... called “Fighting Addiction Together” in the Hall of Legends ... wide receiver and motivational speaker Herman Moore, the goal ... state of addiction in today’s society, highlight the benefits ... to inform the attendees about the options that are ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Residents looking ... quality care in a more convenient location now that ... Partin Village Plaza, 2310 E. Irlo Bronson Memorial Highway, ... located less than a mile away from its original ... décor, more spacious patient areas with digital intraoral and ...
(Date:6/2/2015)... UCLA Health and Exer have completed negotiations and ... urgent care services in Los Angeles County. The ... California Board of Regents and the Exer Board of ... purchase a minority share of four existing Exer urgent ... Northridge and creates opportunity to grow and develop new, ...
(Date:6/2/2015)... June 02, 2015 The nation’s ... lawsuit ( http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) is now underway in ... court documents, opening statements were presented on May ... etchings on the Profemur hip replacement made the ... to snap just three years after it had ...
(Date:6/2/2015)... Radaris ” was featured on NewsWatch as part of its ... coolest applications on the market for iOS, Android, and Windows. ... the app review and shared with viewers can help users ... According to Psychology Today, humans are a curious species by ... is a part of human development. People are using the ...
Breaking Medicine News(10 mins):Health News:Rehabilitation Facility Graduate Shares Her Story at "Fighting Addiction Together" Conference 2Health News:Coast Dental Office Opening In Kissimmee with Expanded Technology 2Health News:UCLA Health Partners With Exer - More Than Urgent Care 2Health News:First of More Than 1,200 Wright Hip Lawsuits Goes to Trial in California Superior Court 2Health News:First of More Than 1,200 Wright Hip Lawsuits Goes to Trial in California Superior Court 3Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2
... , Girling Health Care to utilize Santrax Time and ... , PORT WASHINGTON, N.Y. and AUSTIN, Texas, June ... of information technology solutions to the home healthcare and ... Healthcare company, announced an agreement by which Girling will ...
... Va., June 23 According to a new report from ... screened by doctors for depression. The group said that all ... show potential risk for depression and suicidal tendencies. While there ... of kids, the mental and emotional health of children does ...
... "Deinstallation" Seen Among Physician Groups in Phoenix ... , NASHVILLE, Tenn., June ... intelligence, reports that while health systems and physician groups in ... in adopting electronic medical records (EMR), there is a high ...
... Region recognizes ... ... Medical Center and CHRISTUS St. Vincent Medical Group in Santa Fe, New Mexico, through teamwork, ... in nine months. CHRISTUS Health began managing CHRISTUS St. Vincent in April 2008 ...
... is Nordic Naturals newest product for children, the "ultimate fish ... natural tangerine flavor. Perfect for two-year-olds and up, Nordic Omega-3 ... from anchovies and sardines, two sustainable sources of high quality ... mg of fish oil and offers 136 mg of omega-3. ...
... ... Work Harder for Them to Achieve Better ROI , ... Scottsdale, Ariz. (PRWEB) June 23, 2009 -- In ... leaving enterprises vulnerable to threats. According to the Ponemon Institute, 2008 Cost of a ...
Cached Medicine News:Health News:Harden Healthcare Expands Relationship with Sandata Technologies 2Health News:Should All Kids Be Screened for Depression? This Expert Says Yes and Explains How It Can Save Lives 2Health News:Electronic Medical Record Technology Uptake Faces Challenges 2Health News:CHRISTUS Health New Mexico Region Focuses on Cost Management; Saves $1.8 Million 2Health News:CHRISTUS Health New Mexico Region Focuses on Cost Management; Saves $1.8 Million 3Health News:Nordic Omega-3 Fishies from Nordic Naturals Offers Quality EPA and DHA for Children with 'Kid Pleasin' Taste 2Health News:Lumension Audiocast With Aberdeen Group Highlights How to Reduce IT Costs By Effectively Managing and Securing Endpoints 2Health News:Lumension Audiocast With Aberdeen Group Highlights How to Reduce IT Costs By Effectively Managing and Securing Endpoints 3
ThermoPrep 3's two systems in "one" approach, its capability to accommodate up to two standard microplates and its user-selectable settings offers the versatility and throughput you need in today's l...
... four-color, automated benchtop flow cytometry system that ... Designed specifically to support a wide range ... instrument control, auto-sample loading, and push-button fluidic ... is fully modular so it can be ...
... cytometer especially suited for cell analysis ... CyFlow allows to analyze scatter signals ... fluorescence channels. Data acquisition, analysis, and ... built-in PC employing Partec DPAC software, ...
This unique system combines the analytical power of a research cytometer into a compact, truly walk away, clinical analyzer ergonomically designed to expedite sample throughput....
Medicine Products: